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Introduction
The advent of next-generation sequencing (NGS) technologies 
has unveiled the entire picture of the cellular transcriptome, 
wherein various non-coding RNA (ncRNA) are widely 
expressed from a large part of the genome.1,2 The functional 
significance of ncRNAs is particularly evident for the short 
20- to 31-nucleotide (nt) ncRNAs bound to the family of 
Argonaute proteins.3–5 MicroRNAs (miRNAs), the best-
studied class of such RNAs, are approximately 22 nt in length 
and posttranscriptionally regulate the expression of comple-
mentary target mRNAs. While nearly 2,800 species of human 
miRNAs are currently annotated in the miRBase database,6 
computational analyses of massive RNA-sequencing (RNA-
Seq) data has kept increasing the number of miRNA spe-
cies.7,8 miRNAs are estimated to regulate the expression of 
most protein-coding genes,9 and a wide variety of other short 
and long functional ncRNA species coexist in the cellular 
transcriptome,10,11 exhibiting a tremendous impact of ncRNA-
orchestrated regulatory mechanisms on normal developmen-
tal and physiological processes and diseases.12,13 NGS studies 
have accelerated findings on not only novel ncRNA repertoires 
but also well-characterized fundamental RNA species with 
canonical functions, such as transfer RNAs (tRNAs), which 
stimulated us to revisit their significance and versatility.
tRNAs are 70- to 90-nt ncRNAs that fold into a cloverleaf 
secondary structure and L-shaped tertiary structure. Since 
their discovery in the 1950s, tRNAs have been best known as 
fundamental adapter components of translational machinery, 
where they translate codons in mRNA into amino acids in 
protein.14 The human genome encodes .500 tRNA genes,15 
along with numerous tRNA-lookalikes resembling nuclear 
and mitochondrial tRNAs.16,17 The multitude of tRNA genes 
in the genome, along with high stability,18 places tRNAs 
among the most abundant RNA molecules in the cellular 
transcriptome. Because of their abundance and well-defined 
role in translation, RNA fragments derived from tRNAs, 
found in early NGS studies, were often disregarded as non-
functional degradation products. However, recent biochemi-
cal and bioinformatic evidence has generated a previously 
unsuspected concept that tRNAs are not always end products 
but are further able to serve as a source for short ncRNAs. 
In many organisms, specific tRNA-derived ncRNAs are pro-
duced from mature tRNAs or their precursor transcripts, not 
as random degradation products, but as functional molecules 
involved in many biological processes beyond translation.19–23
tRNA-derived ncRNAs identified to date can be classified 
into two groups: tRNA halves and tRNA-derived fragments 
(tRFs).19–23 tRNA halves are composed of 30–35 nt fragments 
derived from either the 5′- or the 3′-part of mature tRNAs. 
tRFs are shorter than tRNA halves, ranging from 13 to 32 nt 
in length and are currently subclassified into four subgroups: 
5′-tRFs, 3′-CCA tRFs, 3′-U tRFs, and 5′-leader-exon tRFs. The 
5′-tRFs and 3′-CCA tRFs correspond to the 5′- and 3′-parts of 
mature tRNAs containing processed mature 5′- and 3′-CCA 
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termini, respectively (Fig. 1). The 3′-U tRFs are derived from 
the 3′-leader sequence of precursor tRNAs (pre-tRNAs) that 
harbor 3′-terminal uridine stretches, which result from tran-
scriptional termination by RNA polyme rase III at thymidine 
tracts (Fig. 1). The 5′-leader-exon tRFs include the 5′-leader 
sequence of pre-tRNAs and the 5′-part of mature tRNAs. 
Although several excellent reviews have already described the 
repertoire, biogenesis, and functional significance of each class 
of the tRNA-derived ncRNAs,19–23 in this review, we par-
ticularly focus on the tRFs bound to Argonaute proteins and 
summarize their conceivable biogenesis factors and emerging 
roles in gene expression regulation as miRNAs.
trFs Associated with AGo Proteins
In humans, the Argonaute protein family has eight members: 
four of the AGO clade (AGO1–4), which are ubiquitously 
expressed in numerous tissues, and four of the PIWI clade, 
whose expressions are restricted to the germline.3–5 All 
four AGO members associate with miRNAs to form effec-
tor complexes for their posttranscriptional regulatory roles, 
while only AGO2 shows endonucleolytic cleavage activity of 
target mRNAs. Biochemical purification and identification 
of miRNAs and their target mRNAs have been accompli-
shed by purifying AGO proteins using immunoprecipitation 
(AGO-IP) followed by investigation of the AGO-bound RNAs 
in the IP fraction.24,25 Similar sizes of tRFs with miRNAs 
allowed researchers to reason that tRFs may be AGO-bound 
RNA species. Although early studies have already observed 
tRNA-derived sequences from AGO-IP fraction, as described 
below, more recent reports have demonstrated an evident asso-
ciation of the tRNA-derived ncRNAs with AGO proteins. 



















































figure 1. Schematic representation of the biogenesis of miRnas and tRFs associated with aGo proteins.
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derived from the tRNA corresponding to the amino acid and 
anticodon sequences.
The first focused detection of AGO-bound tRNA-
derived ncRNAs in humans was reported in 2009.26 Cole 
et al. identified numerous tRFs in RNA-Seq data from 
HeLa cells.26 Majority of the identified tRFs were 5′-tRFs, 
and 5′-tRFGlnCUG, selected for the analyses, was shown to be 
present in AGO1- and AGO2-IP fractions. This result sug-
gests the loading of the tRF in both of the AGO proteins, 
although 5′-tRFGlnCUG was also found in the fraction where 
AGO proteins were absent and therefore it seems that not all 
tRFs are loaded onto the AGO proteins. Haussecker et al. 
detected 3′-CCA tRFs and 3′-U tRFs in Human Embryonic 
Kidney 293 (HEK293) cells by northern blots.27 Interest-
ingly, the identified tRF was selectively loaded onto differ-
ent AGO proteins; 3′-U tRFSerUGA was found to be loaded 
onto AGO3 and AGO4 but not to AGO1 and AGO2.27 
Burroughs and Ando et al. performed AGO1-3 IPs using 
THP-1 cells followed by NGS of the RNA contents of the 
IP fractions, and identified several 5’-tRFs that were specifi-
cally loaded onto AGO1, but slightly or not at all onto AGO2 
and AGO3.28,29 They also observed the presence of 3′-CCA 
tRFs in their AGO-bound RNA libraries. Li et al. identi-
fied numerous 5′-tRFs and 3′-CCA tRFs in RNA-Seq librar-
ies from BCP1 and HEK293 cells and demonstrated that 
both of the selected tRFs, 3′-CCA tRFHisGUG and 3′-CCA 
tRFLeuCAG, were loaded onto AGO2 but not onto AGO1.30 
Maute et al. focused on 3′-CCA tRFGlyGCC whose expres-
sion levels are regulated by differentiation stages in mature 
B cells.31 The tRF was enriched in the AGO4-IP fraction, 
followed by fractions from AGO1- and AGO3-IPs, but less 
enriched in the AGO2-IP fraction. Kumar et al. analyzed 
many available short RNA libraries and observed numerous 
5′-tRFs, 3′-CCA tRFs, and 3′-U tRFs, whose expression pro-
files varied in different cell lines and tissues.32 Their analyses 
of HEK293 AGO-IP fractions obtained from Photoacti-
vatable-Ribonucleoside-Enhanced Crosslinking and Immu-
noprecipitation (PAR-CLIP)33 suggested that 5′-tRFs and 
3′-CCA tRFs associate with AGO1, AGO3, and AGO4, but 
not with AGO2,32 whereas 3′-U tRFs were absent in all four 
AGO-IP fractions. Positional analyses of crosslink-induced 
mutations in PAR-CLIP data indicated that tRFs were 
loaded onto AGO proteins in a manner similar to miRNAs.32 
Taken together, it could be concluded that the attempts to 
connect tRFs, at least partially, with the miRNA pathway 
have been successful. As miRNAs, some tRF species of the 
three classes (5′-tRFs, 3′-CCA tRFs, and 3′-U tRFs) are the 
interacting partners of AGO proteins.
The presence of tRFs in the AGO-IP fraction has also 
been reported for many other organisms such as mouse,34 
Drosophila,35 and Bombyx,36 as well as in plant.37 Along the 
same lines, PIWI proteins, the other Argonaute family sub-
clade that associates with PIWI-interacting RNAs (piR-
NAs) for germline development,3–5 have also been reported 
to interact with tRNA-derived ncRNAs in various organisms 
such as human,38 marmoset,39 Drosophila,40 Trypanosoma,41 
and Tetrahymena.42,43 Functional significance of the PIWI-
bound tRFs in RNA metabolism has been shown in Tetrahy-
mena.43 These findings suggest that tRNA-derived ncRNAs 
are widely-conserved functional factors across phyla that 
interact with Argonaute family proteins.
biogenesis Factors for AGo-bound trFs
Asymmetric loading of tRFs onto the different AGO pro-
teins could be due to coupling of tRF biogenesis with AGO 
loading mechanism and/or preferences of the AGO pro-
teins and other biogenesis factors for the particular struc-
tures of tRFs or their precursors, namely mature tRNAs 
and pre-tRNAs. Mature tRNAs are produced from pre-
tRNAs, which undergo several maturation steps44 (Fig. 1). 
Pre-tRNAs are first transcribed by RNA polymerase III, 
and their 5′-leader and 3′-trailer sequences are removed by 
endonucleolytic cleavage of RNase P and RNase Z, respec-
tively. The “CCA” trinucleotides are then attached to the 
3′-termini by a CCA-adding enzyme, and various different 
non-canonical base modifications are attached by modification 
enzymes. The resultant mature tRNAs are finally aminoacy-
lated by their cognate aminoacyl-tRNA synthetases. Judging 
from the regions and sequences that the tRFs originate from, 
both pre-tRNAs and mature tRNAs must serve as substrates 
for the production of tRFs.
In vertebrates, canonical miRNA biogenesis (Fig. 1) 
starts from transcription of the miRNA gene by RNA poly-
merase II to generate a primary transcript (pri-miRNA), 
which is subsequently cleaved by Drosha, an endonuclease 
belonging to the RNase III superfamily, forming a complex 
with DGCR8.3–5 The resultant ∼70-nt precursor miRNA 
(pre-miRNA) with a hairpin-shaped structure is further pro-
cessed by Dicer, another RNase III endonuclease, leading to 
the production of RNA duplex, one strand of which is then 
loaded onto AGO proteins.3–5 Considering the expression of 
tRFs complexed with AGO proteins, one may infer Drosha 
and Dicer endonucleases are involved in the production of 
such AGO-loaded tRFs. Indeed, the biogenesis of some tRFs 
belonging to 5′-tRFs, 3′-CCA tRFs, or 3′-U tRFs have been 
reported to be dependent on Dicer in humans,26,27,31 mice,45 
and Drosophila35 (Fig. 1). Furthermore, Dicer is also reported 
to cleave tRNAGlnCUG to generate 5′-tRFGlnCUG in vitro.26 
Although the cloverleaf secondary structure of tRNAs does 
not meet the criteria for canonical Dicer substrates, some pre-
cursor and mature tRNA molecules may alternatively form a 
long hairpin structure, particularly before modifications are 
attached, which may make tRNA structures suitable for Dicer 
processing as predicted in the case of mice tRNAIluUAU.45
Some tRFs seem to be generated via Dicer-independent 
biogenesis mechanism.27,32 Because several non-canonical 
miRNA biogenesis pathways are independent of Drosha or 
Dicer and utilize precursor RNAs forming various structures 
Shigematsu and Kirino
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other than canonical hairpin-loop structures, such as single- 
stranded RNAs, AGO-bound tRFs may be produced through 
such non-canonical pathways.46,47 Alternatively, the other 
enzymes, which are not involved in miRNA biogenesis 
would be involved in the production of AGO-bound tRFs. 
RNase Z cleavage has been shown to produce 3′-U tRFs from 
pre-tRNAs in a Dicer-independent manner.27,48 Moreover, 
Angiogenin (ANG), a member of the RNase A superfamily, 
is the candidate enzyme responsible for AGO-bound tRFs. In 
mammalian cells, ANG was first discovered to be the enzyme 
that cleaves the anticodon loops of mature tRNAs to produce 
tRNA halves upon stress stimuli.49,50 However, it has also 
been shown that ANG is able to cleave the T-loop of tRNAs 
to produce 3′-CCA tRFLysUUU in vitro (Fig. 1),30 although this 
has yet to be confirmed in vivo.
It remains to be elucidated how the biogenesis factors 
are able to access and process the rigid structure of mature 
tRNAs, because, in the cytoplasm, mature aminoacylated 
tRNAs form an L-shaped tertiary structure and are tightly 
bound by an elongation factor to be transported to the 
ribosome. Because tRFs and tRNA halves coexist (e.g., 
5′-tRFs were purified together with 5′-tRNA halves in 
Dicer-immunoprecipitates),36,51–54 the tRNA halves may be 
direct precursors of tRFs in some instances. Because the 
anticodon loop is exposed and accessible in animoacylated 
tRNA–elongation factor complexes, mature tRNAs may 
first be subjected to anticodon cleavage by ANG or other 
nucleases and then the generated tRNA halves dissoci-
ated from an elongation factor may be further processed 
for the production of tRFs. Further analyses are required 
to fully unveil the biogenesis factors and mechanisms for 
AGO-bound tRFs.
Functional significance of AGo-bound trFs Acting 
as mirNAs.
miRNAs deposit AGO proteins onto target RNAs by rec-
ognizing complementary sequences generally located in 
their 3′-UTR.3–5 Imperfect miRNA base-pairing with target 
mRNAs appears to induce translational silencing, whereas 
extensive base-pairing triggers exonucleolytic decay of the 
target mRNAs. Considering their association with AGO 
proteins and their similar size to miRNAs, it is not surpris-
ing that AGO-bound tRFs act as miRNAs and silence the 
expression of their complementary target mRNAs.
Research on viruses has shown the first demonstration 
of AGO-bound tRFs functioning as miRNAs. It has long 
been known that retroviruses use host tRNA as a primer 
for reverse transcription during the first step of retroviral 
replication. The 3′-part of such tRNAs is complementary and 
binds to the primer-binding site (PBS) of the virus sequence. 
In human MT4 T-cells infected with human immuno-
deficiency virus type 1 (HIV-1), Yeung et al. observed the 
abundant expression of an 18-nt 3′-CCA tRFLysUUU which 
is complementary to the PBS of HIV-1.55 Moreover, the 
3′-CCA tRFLysUUU was loaded onto AGO2 and induced 
AGO2-mediated cleavage of the PBS, thereby silencing 
PBS-containing reporter gene and a HIV-1 gene. These 
results suggest important roles of AGO-loaded tRFs on 
repression of virus replication. Because the human genome 
contains many endogenous retroviral sequences and 3′-tRFs 
are highly complementary to these,30 tRF-directed pathways 
may also play ubiquitous roles in silencing endogenous viral 
elements. As another example of the involvement of tRFs 
in viral expression, Wang et al. reported that infection with 
human respiratory syncytial virus (RSV) led to accumulation 
of 5′-tRFs derived from various cytoplasmic tRNAs.56 One 
chosen 5′-tRF, 5′-tRFGluCUC, was shown to be generated by 
ANG-mediated cleavage at sites adjacent to the 5′-end of 
the anticodon loop. Because the 5′-tRFGluCUC showed activ-
ity in repressing complementary reporter gene expression, 
it is highly plausible that the tRF is loaded onto the AGO 
proteins. The tRF was further shown to have functional sig-
nificance in regulating RSV replication.56
In addition to the viral research, Maute et al. reported 
a tRF functioning as miRNA in mature human B cells.31 
A 22-nt AGO-bound 3′-CCA tRFGlyGCC showed activity in 
repressing the expression of target mRNAs in a sequence-spe-
cific manner. RPA1, an essential gene for DNA dynamics and 
repair, was identified as one of the endogenous targets contain-
ing complementary sequences of the tRF in its 3′-UTR. Stable 
expression of the tRF suppressed cell proliferation and modu-
lated the response to DNA damage in an RPA1-dependent 
manner, indicating the clear biological importance of 3′-CCA 
tRFGlyGCC.31 Haussecker et al. used a reporter assay to con-
firm that AGO-bound 3′-CCA tRFs and 3′-U tRFs repressed 
complementary target RNAs.27 These results suggested that 
the tRFs were able to function as miRNAs, although further 
identification of endogenous tRF targets using CLIP25,33 and 
degradome RNA analysis57 will be required to fully under-
stand their biological significance. One of the tRFs used in 
their analysis, a 3′-U tRFSerUGA, was reported to promote cell 
proliferation in the other study by Lee et al.48, validating that 
at least this tRF has an important cellular role. In addition 
to their roles in translational repression in the cytoplasm, 
AGO proteins have been reported to play distinct roles in the 
nucleus, such as modulation of histone methylation, mRNA 
splicing, and DNA damage repair, which is guided by miR-
NAs.58,59 AGO-bound tRFs may be involved in such nuclear 
functions of AGO proteins. Accumulation of further evidence 
of the functionality and endogenous biological roles of AGO-
bound tRFs would lead to clearcut designation of these tRFs 
as regulatory RNA molecules.
Perspectives
The number of reports characterizing expression and func-
tion of tRNA-derived ncRNAs has been growing, which 
en f orces the conceptual consensus that cells utilize mature 
and precursor tRNAs as a source for short, functional 
tRNA-derived short noncoding RNA as partner of argonaute proteins
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ncRNAs. Although this review detailed Argonaute-bound 
tRFs, there are various other classes of tRNA-derived 
ncRNAs that are functional through mechanisms with-
out involvement of  Argonaute proteins. A representative 
example is the tRNA halves, termed tRNA-derived stress-
induced RNAs (tiRNAs),49 whose production through ANG 
cleavage of the tRNA anticodon are triggered by various 
stress stimuli.19–23 tiRNAs promote the stress response by 
stress granule formation60 and global inhibition of transla-
tion by YB-1-involved pathway,49,61,62 thereby associating 
with normal biological processes and diseases.19–23,52 As 
another example of functional tRNA halves, sex hormone-
dependent tRNA-derived RNAs (SHOT-RNAs) have been 
recently identified in breast and prostate cancers.63 SHOT-
RNAs are also produced by ANG cleavage of the tRNA 
anticodon, which is promoted by sex hormones and their 
receptors, and these enhance cell proliferation.63
Despite the findings described in this review, informa-
tion regarding expression profiles, biogenesis pathways, and 
biological meanings of AGO-bound tRFs is still fragmented. 
One of the obstacles for comprehensive identification of the 
tRFs would be the extensive presence of posttranscriptional 
modifications in tRNAs. Over 100 posttranscriptional modi-
fications are present in tRNAs, many of which play crucial 
roles in tRNA folding and function such as codon recogni-
tion.64–67 Because it is highly plausible that many tRNA-
derived ncRNAs are produced from modified tRNAs and 
because many modifications inhibit Watson–Crick base par-
ing and thus arrest reverse transcription,68 heavily modified 
tRNA-derived ncRNAs would not be accurately captured by 
RT-PCR based sequencing methods. Modifications would 
also influence the biogenesis and function of tRNA-derived 
ncRNAs. For example, the presence of base-pairing-inhibi-
tory modification inside the AGO-bound tRF would affect 
the efficiency of targeting and regulation of mRNAs. These 
points based on tRNA biological properties should be borne 
in mind for analyses of tRNA-derived ncRNAs.
As another considerable point, analyses of tRNAs and 
their fragments should be executed by proper bioinformatics. 
Genomes encode many identical tRNA genes and their slightly 
different variants, and identical tRNA fragment sequences 
can be present in non-tRNA regions in the genome.69 Very 
recently, during revising this manuscript, exhaustive analy-
ses of massive RNA-Seq data have newly identified the fifth 
class of tRF, i-tRFs, which are wholly derived from inter-
nal regions of mature tRNAs and are loaded onto AGO 
proteins.70 tRFs including i-tRFs were reported to be dif-
ferentially expressed in different cell types, tissues, disease 
states and human race.70  As in the effort to generate a tRNA 
fragment database by Kumar et al.71, cataloging the expression 
of tRNA fragments in various cell types and tissues, which 
should be based on appropriate bioinformatics approach and 
uniform nomenclatures will accelerate future investigations of 
tRNA-derived ncRNAs.
It is not known why the cells utilize tRNAs for ncRNA 
production. One potential answer may be the regulatory mecha-
nism of tRNA abundance and heterogeneity. tRNA abundance 
varies greatly among different human cells and tissues, and 
the translational regulation by tRNA heterogeneity has been 
suggested.72–74 The expression of tRNA halves is also variable 
in different cells and tissues and further regulated by tRNA 
modification states, various stressors, and hormones.19–23,63 The 
uniquely regulated mechanism in controlling the quality and 
quantity of tRNAs and tRNA halves may consequently result 
in the opportunity for cells to gene rate, from these precursor 
RNAs, specific class of ncRNAs whose species and abun-
dance would then also be uniquely controlled. In that regards, 
as shown in the case of various types of ncRNAs,11 tRNA-
derived ncRNAs may emerge as a source of biomarkers and 
targets for therapeutics. Indeed, use of tRNA-derived ncRNAs 
as indicators for biological states has been suggested.63,70,75,76 
Research on tRNA-derived ncRNAs is still in the initial stage 
and their biological functions may extend beyond our expec-
tations. Further efforts to understand the expression profiles, 
biogenesis, and function of tRNA-derived ncRNAs will 
advance our knowledge regarding the expanding tRNA world 
and may provide significant insights into the pathophysiology 
of diseases.
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